2-amino-5-phosphonovalerate and gastrin-releasing peptide

2-amino-5-phosphonovalerate has been researched along with gastrin-releasing peptide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kallingal, GJ; Mintz, EM2
Amaral, OB; Luft, T; Roesler, R; Schwartsmann, G1

Other Studies

3 other study(ies) available for 2-amino-5-phosphonovalerate and gastrin-releasing peptide

ArticleYear
Glutamatergic activity modulates the phase-shifting effects of gastrin-releasing peptide and light.
    The European journal of neuroscience, 2006, Volume: 24, Issue:10

    Topics: 2-Amino-5-phosphonovalerate; Animals; Circadian Rhythm; Cricetinae; Dicarboxylic Acids; Drug Interactions; Excitatory Amino Acid Antagonists; Gastrin-Releasing Peptide; Glutamic Acid; Light; Male; Mesocricetus; Neurotransmitter Uptake Inhibitors; Photic Stimulation; Pyrrolidines; Suprachiasmatic Nucleus; Third Ventricle

2006
Transient disruption of fear-related memory by post-retrieval inactivation of gastrin-releasing peptide or N-methyl-D-aspartate receptors in the hippocampus.
    Current neurovascular research, 2008, Volume: 5, Issue:1

    Topics: Analysis of Variance; Animals; Avoidance Learning; Bombesin; Excitatory Amino Acid Antagonists; Fear; Gastrin-Releasing Peptide; Hippocampus; Male; Mental Recall; Peptide Fragments; Rats; Rats, Wistar; Reaction Time; Receptors, N-Methyl-D-Aspartate; Time Factors; Valine

2008
An NMDA antagonist inhibits light but not GRP-induced phase shifts when administered after the phase-shifting stimulus.
    Brain research, 2010, Sep-24, Volume: 1353

    Topics: Analysis of Variance; Animals; Behavior, Animal; Circadian Rhythm; Cricetinae; Excitatory Amino Acid Antagonists; Gastrin-Releasing Peptide; Gastrointestinal Agents; Light; Male; Microinjections; Receptors, N-Methyl-D-Aspartate; Suprachiasmatic Nucleus; Time Factors; Valine

2010